Immunotherapy: Open Access
Open Access

Immunosenescence: A Multifactorial Condition Leading to Pathologically Significant Health Problems in Aged People

Tali Feferman^{* *}Correspondence: Tali Feferman, Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel, Email:

Author info »

Editorial Note

Immunosenescence is the normal ageing process that causes the immune system to deteriorate. More so than the innate immune system, the adaptive immune system is harmed. Immunosenescence, along with anergy and T-cell exhaustion, is one of the most common immune system dysfunctional states. Immunosenescence, on the other hand, is thought to be a state that cannot be reversed, unlike T-cell anergy or exhaustion. Both the host's ability to respond to infections and the establishment of long-term immunological memory are involved in Immunosenescence. This age-related immune deficit can be observed in both long- and short-lived animals, and it is determined by their age in terms of life expectancy rather than chronological time. It is thought to be a major contributory factor in the elderly's higher morbidity and mortality rates. Immunosenescence does not appear to be a random deteriorative process rather, it appears to follow an evolutionary pattern in reverse, and most of the Immunosenescence-related parameters appear to be genetically controlled. Immunosenescence is also sometimes thought to be the outcome of the constant challenge of unavoidable exposure to antigens such as viruses and bacteria. Both the creation of new naive lymphocytes and the functional competency of memory cell populations deteriorate with age. This has been linked to an increase in the occurrence and severity of diseases like cancer, chronic inflammatory disorders, breakthrough infections, and autoimmune disease. Infections in the elderly are difficult to diagnose because they typically show with non-specific signs and symptoms, and evidence to a focused infection are frequently lacking or disguised by underlying chronic diseases. This in turn, causes issues with diagnosis and as a result the therapy.

According to the antagonistic pleiotropy theory of ageing, the good benefits of inflammation devoted to the neutralisation of dangerous and harmful substances early in life and in adulthood become deleterious late in life in a period largely not predicted by evolution. It should also be highlighted that changes in the lymphoid compartment are not the main cause of immune system dysfunction in the aged. Although myeloid cell production does not appear to reduce with age, environmental factors cause macrophages to become dysregulated.

The effects of ageing have the greatest impact on T-cell functional capability. In fact, age-related changes can be seen at all phases of T-cell maturation, making them an important element in the progression of Immunosenescence. The progressive involution of the thymus, which is required for T-cell maturation following the migration of precursor cells from the bone marrow, begins the loss of T-cell activity after birth. This age-related decline in thymic epithelial volume leads to a drop/exhaustion in the number of thymocytes, lowering peripheral naive T-cell production. T-cells, once developed and moving throughout the peripheral system, nonetheless go through age-related alterations that are harmful. This scenario, together with age-related thymic involution and the resulting age-related decline in thymic output of new T cells, leaves the body almost bereft of virgin T cells, making it more susceptible to a variety of viral and noninfectious disorders. Human cytomegalovirus (HCMV) is thought to be a primary cause of Immunosenescence in 50% to 85% of adults by the age of 40, while this is debatable.

Immunosenescence, as previously said, is a complex and spontaneous process. The lower T cell output caused by thymus involution, on the other hand, appears to be the most important factor. As a result, restoring thymus growth, which can be accomplished by transplanting proliferative thymic epithelial cells from young mice to elderly or deficient thymuses, can slow down the ageing process.

Author Info